Skip to search formSkip to main contentSkip to account menu

CV 3317

Known as: CV-3317 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Background: Angiotensin converting enzyme (ACE) inhibitors and Angiotensin II (AII) receptor blockers have previously been shown… 
1989
1989
Delapril est administre a dose unique ou a doses repetees et on teste son action antihypertensive et ses effets sur les systemes… 
1988
1988
Pharmacokinetic properties of a new angiotensin‐converting enzyme inhibitor, delapril (CV‐3317), which converts to two active… 
1986
1986
N-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2- yl)glycine hydrochloride (CV-3317) and its de-esterified… 
1986
1986
The antihypertensive action of N-[N-[(S)-1-ethoxycarbonyl-3-phenyl-propyl]-L-alanyl]-N-(indan-2-yl) glycine hydrochloride (CV… 
1986
1986
A new angiotensin converting enzyme (ACE) inhibitor, N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2-yl)glycine…